The work of Jiang et al and our study confirmed that the activation of TME-infiltrating CD8+ T cells induces abnormal RIG-I expression, thereby inhibiting the activation of STAT5 and negatively regulating the phosphorylation of AKT at position 308, which in turn suppresses the anti-tumour function of CD8+ T cells. The gene discussed is RIGI; the disease is neoplasm.